AMOÉBA publishes complete genomic analysis of an amoeba

In France, AMOÉBA, producer of a biological biocide, capable of eliminating bacterial risk in water and human wounds, and a biocontrol product for plant protection, reports the complete sequencing and genome analysis of the Willaertia magna C2c Maky amoeba.

The project was completed with the collaboration with the Institut Hospitalo-Universitaire de Méditerranée Infection in Marseille. Amoéba’s ambition is to become a major player in the treatment of bacterial risk in the fields of water, healthcare and plant protection.

“Knowledge of non-pathogenic amoebas is limited, so sequencing the genome of Willaertia magna C2c Maky is a major step forward in decoding its capabilities. The study shows that this amoeba has a genome containing 36.5 million nucleotide bases. It potentially codes for 18519 proteins, half of which could be assigned to known functions. ” explains Professor Bernard LA SCOLA of the IHU de Méditerranée Infection.

This study is all the more essential as it strengthens the evidence of the Willaertia magna C2c Maky amoeba safety.